Age-Related Macular Degeneration

Age-Related Macular Degeneration (AMD) is a progressive, chronic eye disease that causes central vision loss by damaging the macula, the small area of the retina responsible for sharp, detailed, central vision. It is the leading cause of irreversible blindness in individuals over age
60.

AMD is multifactorial, involving oxidative stress, chronic inflammation, and complement system dysregulation. Genetic susceptibility is significantly linked to variations in the complement factor H (CFH) and ARMS2/HTRA1 genes. Lifestyle factors, particularly smoking, accelerate oxidative retinal damage.

Pathogenesis involves the accumulation of drusen (extracellular deposits) between the retinal pigment epithelium (RPE) and Bruch’s membrane. In dry AMD, atrophy of the RPE leads to photoreceptor loss. In wet (neovascular) AMD, VEGF-driven abnormal choroidal neovascularization (CNV) causes fluid leakage, hemorrhage, and subretinal fibrosis.

Prevalence increases exponentially with age, affecting approximately 10-15% of individuals over

1. It is more prevalent in Caucasians. Gender distribution is roughly equal, though women have a slightly higher lifetime risk due to longer life expectancy.

• Advanced age
• Smoking (highest modifiable risk)
• Family history
• Caucasian ethnicity
• Hypertension and cardiovascular disease
• Low dietary intake of antioxidants/lutein
• Obesity

A. Early Symptoms

• Difficulty reading in dim light


• Mild blurring of central vision B. Common Symptoms


• Metamorphopsia (straight lines appearing wavy)


• Difficulty recognizing faces


• Need for brighter light while reading C. Advanced Symptoms


• Central scotoma (blank dark spots)


• Significant loss of color perception D. Emergency Symptoms


• Sudden, rapid loss of vision


• Rapid onset of a dark curtain over vision

Slit-lamp biomicroscopy reveals presence of hard or soft drusen, RPE pigmentary changes, and, in wet AMD, subretinal fluid or exudative hemorrhage.

A. Clinical Assessment: Dilated fundus examination.
B. Laboratory Testing: Generally not required for diagnosis.
C. Imaging Studies: Optical Coherence Tomography (OCT), Fluorescein Angiography (FA).
D. Functional Tests: Amsler Grid, visual acuity chart.
E. Biopsy Findings: Not indicated clinically.
F. Genetic Testing: Available but not routinely recommended for general screening.
G. Differential Diagnosis: Diabetic retinopathy, central serous chorioretinopathy, epiretinal membrane.

None specifically required for diagnosis; however, metabolic screening for cardiovascular comorbidities is advised.

1. OCT: High-resolution cross-sectional images to detect fluid/drusen.
2. Fluorescein Angiography (FA): Uses dye to visualize active neovascular leakage.

Central Serous Chorioretinopathy (usually younger patients), Myopic Maculopathy, Diabetic Macular Edema.

Permanent central visual impairment, legal blindness, and profound secondary psychological impact (depression).

A. Lifestyle Modifications: Smoking cessation, diet high in leafy greens (lutein/zeaxanthin).
B. Preventive Measures: AREDS2 vitamin supplementation.
C. Medical Treatment: Anti-VEGF injections (e.g., Aflibercept, Ranibizumab) for wet AMD.
D. Surgical Treatment: Rarely used; vitrectomy for subretinal hemorrhage.
E. Interventional Procedures: Photodynamic therapy (niche).
F. Rehabilitation: Low-vision aids, telescopic lenses.
G. Emergency Management: Urgent anti-VEGF for acute wet AMD flares.

Early dry AMD can be stable for years. Wet AMD, if untreated, leads to rapid central vision loss but can be managed with anti-VEGF injections to stabilize vision. Peripheral vision is typically preserved.

Smoking cessation, use of sunglasses, regular eye examinations for those >
50.

The following homeopathic remedies have been historically indicated for symptoms associated with Age-Related Macular Degeneration. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Age-Related Macular Degeneration.